US FDA Warns Torrent Over Losartan Process Validation, OOS Invalidation Failures

 
• By Bowman Cox
  
Vintage inscription made by old typewriter, warning
Letter is another sign of the increased scrutiny the valsartan crisis has brought to pharmaceutical manufacturers.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance